Cargando…

Antineoplastics: Secondary immunodeficiencies: 5 case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149127/
http://dx.doi.org/10.1007/s40278-016-22766-8
_version_ 1783520743421640704
collection PubMed
description
format Online
Article
Text
id pubmed-7149127
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491272020-04-13 Antineoplastics: Secondary immunodeficiencies: 5 case report Reactions Weekly Case Report Springer International Publishing 2016-11-12 2016 /pmc/articles/PMC7149127/ http://dx.doi.org/10.1007/s40278-016-22766-8 Text en © Springer International Publishing Switzerland 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Antineoplastics: Secondary immunodeficiencies: 5 case report
title Antineoplastics: Secondary immunodeficiencies: 5 case report
title_full Antineoplastics: Secondary immunodeficiencies: 5 case report
title_fullStr Antineoplastics: Secondary immunodeficiencies: 5 case report
title_full_unstemmed Antineoplastics: Secondary immunodeficiencies: 5 case report
title_short Antineoplastics: Secondary immunodeficiencies: 5 case report
title_sort antineoplastics: secondary immunodeficiencies: 5 case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149127/
http://dx.doi.org/10.1007/s40278-016-22766-8